---
title: G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells
date: '2024-06-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38879607/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240616180959&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Neurofibromatosis Type II (NFII) is a genetic condition caused by loss
  of the NF2 gene, resulting in activation of the YAP/TAZ pathway and recurrent Schwann
  cell tumors, as well as meningiomas and ependymomas. Unfortunately, few pharmacological
  options are available for NFII. Here, we undertake a genome-wide CRISPR/Cas9 screen
  to search for synthetic-lethal genes that, when inhibited, cause death of NF2 mutant
  Schwann cells but not NF2 wildtype cells. We identify ACSL3 and G6PD as ...
disable_comments: true
---
Neurofibromatosis Type II (NFII) is a genetic condition caused by loss of the NF2 gene, resulting in activation of the YAP/TAZ pathway and recurrent Schwann cell tumors, as well as meningiomas and ependymomas. Unfortunately, few pharmacological options are available for NFII. Here, we undertake a genome-wide CRISPR/Cas9 screen to search for synthetic-lethal genes that, when inhibited, cause death of NF2 mutant Schwann cells but not NF2 wildtype cells. We identify ACSL3 and G6PD as ...